drugset / Trial / NCT00908271
Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects
NaSingle-groupOpen-label
Summary
The purpose of this study is to estimate the absolute oral bioavailability of dapagliflozin.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 100 ug | Oral |
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |